Recent Advances in AIDS and HIV Research

艾滋病和艾滋病毒研究的最新进展

• 批准号: 8705971
• 负责人: PAUL A VOLBERDING
• 金额: $ 1.5万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-09-01 至 2017-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8705971
• 关键词: AIDS/HIV problem; Acquired Immunodeficiency Syndrome; Administrator; Advertising; Area; Award; Biometry; Clinical; Collaborations; Communication; Country; Development; Environment; Ethnic group; Fostering; Funding; Funding Opportunities; Future; HIV; HIV Infections; Individual; Infection; Institutes; Institution; Internet; Investigation; Leadership; Link; Location; Malignant Neoplasms; National Institute of Mental Health; Outcome; Participant; Prevention; Research; Research Personnel; Scholarship; Site; Staging; System; Travel; United States National Institutes of Health; Universities; Vaccines; Viral; Woman; base; behavioral/social science; career; continuing medical education; health disparity; interest; meetings; next generation; posters; preference; programs; research and development; symposium; working group

Description (as provided by the applicant): Since 1998, the NIH-funded Centers for AIDS Research (CFAR) have hosted an annual one day National CFAR Scientific Symposium in conjunction with the annual CFAR Directors'/Administrators' meeting. The purpose of the CFAR scientific symposium is to present, in a public forum, recent "cutting edge" advances in HIV/AIDS research for an average attendance of approximately 250-300. The intimate size of the meeting promotes opportunities for interactions between young and more senior investigators that would not be available at the larger annual scientific meetings related to HIV/AIDS. The meeting location rotates so that it is hosted each year by a different CFAR site. This provides geographic diversity for the venue and opportunities for a broader array of participants than for similar research symposia. As has been done for the past fifteen years, one of several AIDS-related research areas is the focus of the annual symposium. In 2011, the Duke University CFAR hosted the 15th Annual CFAR Research Symposium with focus on five scientific areas: "Host-Viral Interactions during HIV Infection", "HIV-Associated Malignancies and Co-Infections", "Emerging Vaccine Strategies", "HIV/AIDS Health Disparities", and "Approaches to an HIV Cure". Speakers were selected from the various NIH-funded Centers for AIDS Research leadership, their scientific membership, and from nationally and internationally recognized research institutions. In addition to the participating CFAR Directors and invited leaders in the field, the remaining participants for the annual National CFAR Symposia are chosen based on specific criteria. First preference is given to young investigators who have received developmental funds from an NIH-funded CFAR program; second preference to young investigators with demonstrable potential in HIV/AIDS research; third preference is to other senior investigators engaged in HIV/AIDS research. In all cases women and individuals from underrepresented ethnic groups are encouraged to attend through targeted advertising and travel scholarships. Continuing Medical Education credits have been offered for attendees and access to web casts of the symposia are now available for interested investigators who are not able to attend.

描述（由申请人提供）：自1998年以来，美国国立卫生研究院资助的艾滋病研究中心（CFAR）每年举办一次为期一天的国家CFAR科学研讨会，同时举办年度CFAR主任/管理员会议。CFAR科学研讨会的目的是在公共论坛上介绍艾滋病毒/艾滋病研究的最新“前沿”进展，平均出席人数约为250-300人。会议的紧凑规模促进了年轻研究人员和更资深的研究人员之间的互动机会，这是与艾滋病毒/艾滋病有关的大型年度科学会议所没有的。会议地点轮换，因此每年由不同的CFAR站点主办。与类似的研究专题讨论会相比，这为场地提供了地理多样性，并为更广泛的参与者提供了机会。正如过去15年所做的那样，几个与艾滋病相关的研究领域之一是年度研讨会的重点。2011年，杜克大学CFAR主办了第15届CFAR年度研究研讨会，重点关注五个科学领域：“艾滋病毒感染期间宿主-病毒相互作用”、“艾滋病毒相关恶性肿瘤和合并感染”、“新兴疫苗战略”、“艾滋病毒/艾滋病健康差距”和“治愈艾滋病毒的方法”。演讲者从美国国立卫生研究院资助的各个艾滋病研究中心的领导、他们的科学成员以及国内和国际公认的研究机构中挑选出来。除了参加CFAR的主任和该领域的受邀领导外，每年的全国CFAR研讨会的其他参与者是根据特定标准选择的。优先考虑获得美国国立卫生研究院资助的CFAR项目发展资金的年轻研究人员；其次优先考虑在艾滋病毒/艾滋病研究方面具有明显潜力的年轻研究人员；第三优先考虑从事艾滋病毒/艾滋病研究的其他高级研究员。在所有情况下，都鼓励妇女和代表人数不足的族裔群体的个人通过有针对性的广告和旅行奖学金参加。已经为与会者提供了继续医学教育学分，现在有兴趣不能参加的研究人员可以访问研讨会的网络直播。